促销时间表 Shin Nippon Biomedical Laboratories, Ltd.
关于公司 Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., контрактная исследовательская организация, предоставляет услуги по открытию и разработке лекарств в Японии и за рубежом. Он предлагает доклинические лабораторные услуги, такие как проверки надлежащей лабораторной практики; исследования общей и специфической токсичности; патологоанатомические исследования; ПК/ФД биофармацевтических препаратов, тесты на иммунотоксичность и производство антител; исследования репродуктивной токсичности и токсичности для развития; фармакология и исследования фармакологической эффективности; и услуги визуализации. 更多详情Див.доход ао | 5.72 |
---|---|
Дивиденд ао | 50 |
Сайт | https://www.snbl.co.jp |
Цена ао | 1506 |
每日价格变化: | +0.5312% (1506) |
---|---|
每周价格变化: | -3.69% (1572) |
每月价格变化: | -11.2% (1705) |
3个月内价格变化: | -2.57% (1554) |
六个月内的价格变化: | +25.33% (1208) |
每年价格变化: | -9.77% (1678) |
年初以来价格变化: | -2.7% (1556) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Vanguard International Stock Index-Total Intl Stock Indx | 267904 | 0.64 |
Principal International Small Company Fd | 149700 | 0.36 |
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 148621 | 0.36 |
DFA Japanese Small Company Series | 134300 | 0.32 |
iShares Core MSCI EAFE ETF | 118300 | 0.28 |
DFA International Core Equity Portfolio | 103700 | 0.25 |
iShares MSCI EAFE Small Cap ETF | 83400 | 0.2 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 71400 | 0.17 |
iShares International Small-Cap Equity Factor ETF | 68400 | 0.16 |
WisdomTree Tr-WisdomTree Japan Hedged Equity Fd | 43000 | 0.1 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. | Chairman, CEO, President, Head of Fisheries Business & CHO | 144.06M | 1958 (67 年) |
Fumihiko Makino | Senior Executive Officer, Financial Controller and GM of Finance & Accounting | N/A | |
Toshiyuki Iwata | Managing Executive Officer and GM of IR Public Relations Department & Sustainability | N/A | |
Shinji Nitanda | Senior MD of Corporate Development & Corporate Tax Administration and Director | N/A | 1968 (57 年) |
Kyomi Nagatoshi | Managing Executive Officer, Head of General Affairs & Human Resources and Director | N/A | |
Mr. Ken Takanashi CPA, MBA. | Executive VP of Group Corporate Management & Global Business & Director | N/A | 1964 (61 年) |
Dr. Hideshi Tsusaki DVM Ph.D. | Senior MD, President of Non-Clinical & Global Business Development and Director | N/A | 1967 (58 年) |
Terumasa Hirai | Managing Executive Officer, Preclinical Company VP & Director of Safety Research Institute | N/A | |
Mr. Ichiro Nagata | Executive VP, Head of CRO Business, Head of Hospitality Business & Director | N/A | 1985 (40 年) |
Mr. Eishi Tsunozaki | Senior MD & Director | N/A | 1967 (58 年) |